Search Count: 5
 |
Discovery Of A Novel, Highly Potent, And Selective Thieno[3,2-D]Pyrimidinone-Based Cdc7 Inhibitor With A Quinuclidine Moiety (Tak-931) As An Orally Active Investigational Anti-Tumor Agent
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.65 Å Release Date: 2020-01-15 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: O1S |
 |
Discovery Of A Novel, Highly Potent, And Selective Thieno[3,2-D]Pyrimidinone-Based Cdc7 Inhibitor With A Quinuclidine Moiety (Tak-931) As An Orally Active Investigational Anti-Tumor Agent
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:3.30 Å Release Date: 2020-01-15 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: O1V |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:3.00 Å Release Date: 2013-02-06 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: 1FM |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.50 Å Release Date: 2005-12-20 Classification: TRANSFERASE Ligands: F29 |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.50 Å Release Date: 2005-09-13 Classification: TRANSFERASE Ligands: FRZ |